Navigation Links
Drug Refused to Asbestos-Linked Cancer Patients

A body that is responsible for approving NHS treatments has been accused of placing money before patients//, after it blocked the usage of an anti-cancer drug.

The group analyzed the cost effectiveness of the drug, used to treat the cancer mesothelioma, and concluded that the drug would not be recommended for use except as part of ongoing or new.trial.

Mesothelioma is a kind of cancer that affects the lung lining and nine out of ten cases are due to exposure to asbestos. People who are involved in shipbuilding, railway engineering and asbestos product manufacturing are at an increased risk. . A cure for the disease is not available and pemetrexed disodium treatment is used to maintain the quality of life.

The makers of the drug, Eli Lilly, said it will appeal against the decision. Medical director of Lilly UK, Dr Joanna Nakielny, said: "This is a major blow for patients with mesothelioma, many of whom were unwittingly exposed to asbestos in their working lives making submarines, ships, boilers and trains”.

"This treatment does not save lives, but it can prolong the lives of patients and also improve the quality of the time they have left. Lilly will be formally appealing NICE’s decision." She added.


Page: 1

Related medicine news :

1. Smoker Refused Treatment
2. Boy Refused Compensation For HIV Infection Following Hospital Admission
3. One in Ten NHS Dentists Refused To Sign the New Contract
4. Gardasil Refused Subsidy
5. NRI Fights for HIV Child Who was Refused Treatment
6. Fibroids unlikely to Turn Cancerous
7. Virus Level could Predict Cervical Cancer Risk
8. Cancer Doctors Okays Controversial Prostate Therapy
9. Potential New Cancer Gene Identified
10. Consensus on "Combination Therapy" for Breast Cancer
11. Cancers of Colon & Rectum linked to Cigarette Smoking
Post Your Comments:

(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: